Literature DB >> 17526825

Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?

Ann V Schwartz, Deborah E Sellmeyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526825     DOI: 10.2337/dc07-0554

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

Review 1.  Network-based approaches in drug discovery and early development.

Authors:  J M Harrold; M Ramanathan; D E Mager
Journal:  Clin Pharmacol Ther       Date:  2013-09-11       Impact factor: 6.875

Review 2.  The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.

Authors:  Jeffrey M Peters; Yatrik M Shah; Frank J Gonzalez
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

3.  The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study.

Authors:  F-Y Hsiao; C D Mullins
Journal:  Diabetologia       Date:  2009-11-27       Impact factor: 10.122

Review 4.  Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer.

Authors:  Tae Il Kim
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

Review 5.  Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive.

Authors:  John Dormandy; Mondira Bhattacharya; Anne-Ruth van Troostenburg de Bruyn
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.

Authors:  C Eller-Vainicher; E Cairoli; G Grassi; F Grassi; A Catalano; D Merlotti; A Falchetti; A Gaudio; I Chiodini; L Gennari
Journal:  J Diabetes Res       Date:  2020-05-22       Impact factor: 4.011

Review 7.  Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review.

Authors:  Vittoria Russo; Rui Chen; Reina Armamento-Villareal
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-18       Impact factor: 5.555

8.  Betulinic acid decreases lipid accumulation in adipogenesis-induced human mesenchymal stem cells with upregulation of PGC-1α and UCP-1 and post-transcriptional downregulation of adiponectin and leptin secretion.

Authors:  Sasithon Senamontree; Thitiporn Lakthan; Pornsri Charoenpanich; Chanpen Chanchao; Adisri Charoenpanich
Journal:  PeerJ       Date:  2021-10-14       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.